Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Spectral Medical Inc (EDT.TO)

Spectral Medical Inc (EDT.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spectral Medical Inc 135 The West Mall Unit 2, Finance Toronto ON M9C 1C2 CAN

https://www.spectraldx.com P: 416-626-3233 F: 416-626-7383

Description:

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.

Key Statistics

Overview:

Market Capitalization, $K 123,966
Shares Outstanding, K 278,576
Annual Sales, $ 1,598 K
Annual Net Income, $ -15,662 K
Last Quarter Sales, $ 365 K
Last Quarter Net Income, $ -6,555 K
60-Month Beta -0.23
% of Institutional Shareholders 0.03%

Growth:

1-Year Return 74.51%
3-Year Return -14.42%
5-Year Return 30.88%
5-Year Revenue Growth -16.08%

Per-Share Information:

Latest Earnings Date 05/10/24
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Most Recent Dividend 0.120 on 12/19/11
Next Ex-Dividends Date 12/19/11
Dividend Payable Date 01/20/12
Dividend Payout Ratio 0.00%

EDT.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -182.04%
Profit Margin % -980.10%
Debt/Equity N/A
Price/Sales 77.57
Price/Book N/A
Book Value/Share -0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar